Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for Cancer Treatment
Phase 2
32
about 3.2 years
18+
1 site in CA
What this study is about
This trial is testing whether positron emission tomography (PET) guided stereotactic body radiation therapy (SBRT) can safely treat cancer that has spread to multiple locations. The goal is to see if PET-guided SBRT works better than standard SBRT in treating non-small cell lung cancer, melanoma, and renal cell carcinoma with oligoprogressive disease.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Questionnaire Administration
- 2.Receive Stereotactic Body Radiation Therapy
- 3.Undergo Biospecimen Collection
- +2 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Incidence of adverse events, Overall survival, Quality of life (QOL), Time to progression
diagnostic, imaging, radiation
Oncology